The demise of Neil Woodford’s investment empire is continuing to drag on the UK biotech sector, with news that the sell off of shares in privately held life sciences companies has fallen flat.
Woodford was for many years a champion of the UK biotech sector, but a series of missteps saw the value...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)


